From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona’s bioscience industry has grown in recent years and by 2014 state bioscience firms employed just over 24,000 in nearly 1,300 business establishments. Four of the state’s five bioscience subsectors have contributed to its 2 percent overall employment gain since 2012, led by double-digit job growth in medical devices (up 11 percent). State academic institutions accounted for nearly $400 million in bioscience-related R&D expenditures in 2014 and NIH funding to these and other non-academic institutions totaled $150.6 million in 2015. Arizona inventors have had 1,751 patents issued in bioscience-related classes since 2012, primarily in medical and surgical devices but also in drugs and pharmaceuticals, microbiology and genetics, and in biochemistry. The state has seen a strong increase in venture capital invested in bioscience-related companies in recent years. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Most multiple myeloma studies involve people of European descent, but the disease is more likely to affect African-Americans
Last year, pancreatic cancer overtook breast cancer as the third leading cause of cancer deaths. WIth a five-year survival rate of just 8 percent, it is one of the deadliest forms of cancer.
For 14 years, the Mayo Clinic and ASU seed grant program has been funding – or seeding –new research collaborations between ASU and Mayo Clinic researchers aimed at improving patient care. By launching novel research on a small scale, researchers have been able to attract funding needed for larger studies and are making significant impact in […]
CEO to give update on clinical pipeline and lead drug CPP-1X
- Cancer is a Family Affair - AZMN Cancer Caregivers Education Program
- UA College of Medicine - Phoenix Mini Med School: Alzheimer's
- AZBio Trailblazers 2017
- State Biotech Kick Off Reception - JPM Week
- San Francisco
- Biotech Showcase 2018
- 01/08/2018 - 01/10/2018
- San Francisco